HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling.

AbstractOBJECTIVE:
To evaluate the role of different clinical, biochemical and sonographic factors as predictors of spontaneous ovulation after laparoscopic ovarian drilling (LOD) in women with clomiphene citrate resistant polycystic ovarian disease (CCR-PCOD).
STUDY DESIGN:
This prospective study recruited 251 infertile women with CCR-PCOD. Several clinical, biochemical and sonographic criteria were tested as possible predictors of spontaneous ovulation after LOD using multivariate analysis.
RESULTS:
Women with higher preoperative levels of LH, FSH and/or androstenedione had significantly higher rates of spontaneous ovulation within the first eight weeks after LOD, but only FSH and androstenedione were found to be independent predictors. Other factors including age, BMI, type of infertility, duration of infertility, menstrual pattern, testosterone level, ovarian volume and SHBG were insignificant predictors. Receiver-operating characteristic (ROC) curves derived from FSH, LH, androstenedione, and a logistic regression model showed that the best cut-off values were 4.1IU/l, 7.8IU/l, 1.2ng/ml, and 0.4897, respectively, with sensitivity of 91.18%, 100%, 73.53%, and 88.24% and specificity of 69.57%, 69.57%, 65.22%, and 73.91% for FSH, LH, androstenedione, and logistic regression model respectively. An extended follow up (9 months after LOD) was conducted for the anovulatory and the non-pregnant ovulatory women, who were treated individually according to their clinical situation. Of these women, 53.5% (69/129) got pregnant, resulting in a cumulative pregnancy rate of 48% (82/171). Of these pregnancies, 16/82 (19.5%) were spontaneous while 35.4% (29/82) and 45.1% (37/82) occurred after ovulation induction by CC and gonadotropins, respectively.
CONCLUSION:
This study supports the use of androstenedione, LH and FSH as a simple reliable tool in triaging patients with CCR-PCOD to select the ideal candidates for LOD.
AuthorsWessam M Abuelghar, Hassan A Bayoumy, Mohamed I Ellaithy, Marian S Khalil
JournalEuropean journal of obstetrics, gynecology, and reproductive biology (Eur J Obstet Gynecol Reprod Biol) Vol. 175 Pg. 178-85 (Apr 2014) ISSN: 1872-7654 [Electronic] Ireland
PMID24576485 (Publication Type: Clinical Trial, Journal Article)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Fertility Agents, Female
  • Sex Hormone-Binding Globulin
  • Clomiphene
  • Androstenedione
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
Topics
  • Adult
  • Androstenedione (blood)
  • Clomiphene (therapeutic use)
  • Female
  • Fertility Agents, Female (therapeutic use)
  • Follicle Stimulating Hormone (blood)
  • Humans
  • Laparoscopy
  • Luteinizing Hormone (blood)
  • Ovary (diagnostic imaging, surgery)
  • Ovulation
  • Polycystic Ovary Syndrome (blood, drug therapy, surgery)
  • Prospective Studies
  • Sex Hormone-Binding Globulin (metabolism)
  • Treatment Failure
  • Ultrasonography
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: